Company Filing History:
Years Active: 2022-2025
Title: ChuanDer Huang: Innovator in Endoxifen Research
Introduction
ChuanDer Huang is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of endoxifen, a compound with potential applications in treating hormone-dependent disorders. With a total of six patents to his name, Huang's work is recognized for its industrial scalability and therapeutic potential.
Latest Patents
Huang's latest patents focus on methods for making and using endoxifen. The disclosures provide industrially scalable methods for producing (Z)-endoxifen or its salts, as well as crystalline forms of endoxifen. These patents also outline methods for treating hormone-dependent breast and reproductive tract disorders, showcasing the therapeutic applications of his research.
Career Highlights
ChuanDer Huang is currently associated with Atossa Therapeutics, Inc., where he continues to advance his research in the pharmaceutical field. His innovative approaches have positioned him as a key figure in the development of treatments for hormone-related conditions.
Collaborations
Huang collaborates with notable colleagues, including Steven C. Quay and Yao-Lin Sun. These partnerships enhance the research and development efforts at Atossa Therapeutics, Inc., contributing to the advancement of medical science.
Conclusion
ChuanDer Huang's work in the field of endoxifen research exemplifies the impact of innovation in pharmaceuticals. His patents and collaborations reflect a commitment to improving treatments for hormone-dependent disorders.